Koerdt Steffen, Ristow Oliver, Wannhoff Andreas, Kübler Alexander C, Reuther Tobias
Department of Oral and Maxillofacial Plastic Surgery, University of Wuerzburg, Pleicherwall 2, D-97070, Wuerzburg, Germany,
Clin Oral Investig. 2014 Jan;18(1):179-88. doi: 10.1007/s00784-013-0938-y. Epub 2013 Feb 13.
This study aims to evaluate the expression of various immunohistochemical growth factors and vascularization markers in augmentation on the mandible comparing onlay bone grafts and Guided Bone Regeneration (GBR).
Using a sheep in vivo model, autogenous bone grafts were harvested from the iliac crest. A combination of a resorbable collagen membrane (CM) and a Deproteinized Bovine Bone Material (DBBM) was performed. This modification of the host side was compared with an onlay bone graft control group. Expression of different vascularization markers was compared between these groups.
The expression of revascularization markers was significantly higher within the modification of the host side using GBR and DBBM. Regarding different graft regions, a significantly higher expression within the bone graft using GBR and DBBM could be observed in staining on bone morphogenetic protein-2 (BMP-2) (5.75 vs. 3.55), vascular endothelial growth factor (VEGF) (3.08 vs. 1.64), VEGF Receptor 1 (VEGFR-1) and VEGF Receptor 2 (VEGFR-2) (4.88 vs. 2.24 and 5.06 vs. 2.74), and endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) (5.29 vs. 3.28 and 5.22 vs. 3.09; p = 0.000, all others p < 0.05), whereas the control group showed a higher rate of resorption during the surveillance period until euthanasia of sheep after 16 weeks.
The use of GBR and DBBM in the transplantation process of autogenous bone grafts compared with the therapeutical use of certain growth factors may enhance vascularization and lower atrophy and resorption.
The use of a combination of GBR and DBBM in augmentation procedures on the mandible shows less resorption than simple onlay bone grafts and seems to be superior in a clinical use.
本研究旨在评估在下颌骨增量术中,通过比较块状骨移植和引导骨再生(GBR),各种免疫组化生长因子和血管生成标志物的表达情况。
采用绵羊体内模型,从髂嵴获取自体骨移植材料。使用可吸收胶原膜(CM)和脱蛋白牛骨材料(DBBM)进行联合应用。将宿主侧的这种改良方法与块状骨移植对照组进行比较。比较两组之间不同血管生成标志物的表达情况。
在使用GBR和DBBM对宿主侧进行改良的情况下,再血管化标志物的表达明显更高。对于不同的移植区域,在使用GBR和DBBM的骨移植中,骨形态发生蛋白-2(BMP-2)染色(5.75对3.55)、血管内皮生长因子(VEGF)(3.08对1.64)、VEGF受体1(VEGFR-1)和VEGF受体2(VEGFR-2)(4.88对2.24和5.06对2.74)以及内皮型一氧化氮合酶(eNOS)和诱导型一氧化氮合酶(iNOS)(5.29对3.28和5.22对3.09;p = 0.000,其他均p < 0.05)的表达明显更高,而在监测期直至16周后绵羊安乐死期间,对照组的吸收速率更高。
与某些生长因子的治疗性应用相比,在自体骨移植过程中使用GBR和DBBM可能会增强血管生成并降低萎缩和吸收。
在下颌骨增量手术中使用GBR和DBBM联合应用显示出比单纯块状骨移植更少的吸收,并且在临床应用中似乎更具优势。